Gormley Glenn
SEC insider (Form 3/4/5 filer). CIK 0002127198. Director at Aktis Oncology, Inc. (AKTS). 1 reported Form 4/5 transaction since Sep 2024; latest on Apr 15, 2026. Located in BOSTON, MA.
Companies Gormley Glenn has filed insider reports for
- Aktis Oncology, Inc. (AKTS): Director
Gormley Glenn
CIK: 0002127198
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
AKTS
Aktis Oncology, Inc.
Director